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Introduction
Cancer is a global public health problem that 
continues to face treatment accessibility barriers 
in many medically underserved areas.[1] The 
Surveillance, Epidemiology and End Results 
program data of the National Cancer Institute 
indicate an overall increase in the number of 
cancer survivors.[2,3] Such an increase may be 
explained by improved health-care accessibility, 
particularly to remote and rural areas, and 
by enhanced methods of early detection. An 
important advancement that has contributed 
significantly to enhancing access to cancer care is 
the reemergence of telemedicine as a health-care 
delivery system.[4]
Telemedicine can generally be defined as using 
electronic telecommunication signals to transfer 
medical information from one clinician to another 
between distant locations for the purpose of 
facilitating the prevention, diagnosis and treatment 
of medical conditions or for the furtherance 
of research and education.[5,6] Early forms of 
telemedicine utilised telephone wires to transmit 
data. As technology advanced, the television was 
incorporated to facilitate medical consultations.[6] 
The mode by which these electronic signals are 
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Abstract
Introduction: In recent years, we have witnessed significant growth in 
the employment of technological advancements in health-care practices. 
These advancements have increased the practicality and utility of 
telemedicine applications. The aim of this focused review is to provide 
in-depth insights into the current state of telemedicine in oral oncology. 
Observations: Tele-oral oncology (TOO) is a rapidly emerging field and 
has provided new opportunities to transform oral cancer care into the 
22nd century. This review will explore topics related to TOO as they pertain 
to consultation, oral cancer management in underserved areas, patient 
education and e-learning applications. Conclusion and Relevance: The 
utilisation of TOO is hindered by many challenges and this review addresses 
the potential limitations that prevent the integration of TOO in routine oral 
cancer care. A working model that circumvents the potential shortcomings 
of TOO is also proposed.
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transferred has shifted in recent years toward a more 
digitalised and wireless manner, accommodating 
the continuously evolving digital age we live in; 
hence, telemedicine now mostly relies (and soon 
exclusively) on high-speed internet. The Digital 
Medicine Society defines digital medicine as the 
field that supports and promotes the practice of 
medicine and human health using available high-end 
technological advances in software and hardware.[7] 
Applying the concepts of telemedicine to oncology 
is referred to as teleoncology. Teleoncology 
includes a spectrum of health-care services from 
consultation and diagnosis to treatment planning, 
follow-up and recall. Additional applications of 
teleoncology include research and education.[8]
Cancers of the head and neck account for the 
sixth most common cancer type worldwide, with 
the oral cavity being a common anatomic site 
of involvement.[9] Epidemiologic data on the 
incidence, morbidity and mortality of oral cancer 
are variable, especially across different populations, 
due to differences in genetic and environmental 
contributing factors.[10,11] In 2018, the International 
Agency for Research on Cancer estimated 354,864 
new cases and 177,384 deaths from lip and oral 
cavity cancers with the highest incidence, 5-year 
prevalence and mortality being among Asian and 
European populations.[11]
While teleoncology has made significant strides 
in improving cancer-related quality of life, 
demonstrated adequate patient and provider 
satisfaction and has provided us with a multitude 
of potential applications,[1,8,12,13] there is limited 
information available about the extent and use of 
these technologies to advance oral oncology (Tele-
oral Oncology [TOO]) in health care and academia.
The aim of this review is to provide focused in-
depth insights into TOO to dental and medical 
specialists with an emphasis on consultation, 
oral cancer management in underserved areas, 
patient education and e-learning applications. 
In addition, light is shed on potential challenges 
and medicolegal considerations that health-care 
providers should consider when adopting TOO in 
their practices and of significance; future directions 
and a working model that circumvents the potential 
shortcomings of TOO will be proposed.
The Current State of TOO
Many studies have concluded that telemedicine 
is viable and enhances health-care efficiency and 
other studies have acknowledged telemedicine 
as a promising complimentary approach when 
used alongside in-person consultations.[14] On the 
contrary, some studies argue that the effectiveness 
of telemedicine is considered highly variable 
depending on the field evaluated, with limited 
and inconsistent data on its effectiveness.[14] In 
the majority of studies, teleoncology is deemed 
beneficial in terms of screening, supportive 
and emotional care, palliative care, diagnosis 
and treatment[15] with some reported potential 
disadvantages necessitating further research 
to improve the discipline.[16] Although there is a 
paucity of studies that focus on TOO exclusively, an 
emergence of teleoncology in the past decade has 
become apparent. Moreover, the potential of TOO 
and its implications on health care and education 
will be discussed in the succeeding sections.
Patient Education and Care
Teleoncology has been shown to be an effective 
and acceptable model to deliver cancer-related 
education and real-time monitoring post-diagnosis 
and post-treatment to patients through phone 
messaging, calls and video communications.[13,17] 
The patient acceptance has been positive due to 
the immediate access, reduced waiting times to 
communicate with their provider, the reduced cost 
(e.g.,  travelling long distances to appointments) 
compared to face-to-face appointments and the 
accessibility of medical advice and treatment 
planning from a multidisciplinary health-care 
team.[13,17,18] To establish optimal oral cancer care 
through TOO, a multidisciplinary team trained in 
telehealth models is crucial and this team would 
ideally consist of a gamut of dental and medical 
specialists such as oral medicine specialists, oral and 
maxillofacial pathologists, oral radiologists, oral and 
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maxillofacial surgeons, oncologists and maxillofacial 
prosthodontists. Such a multidisciplinary approach is 
crucial for comprehensive high-quality patient care 
and large specialty teams of this nature, especially 
in underserved areas, are otherwise difficult to 
achieve without telemedicine. Figure  1 proposes 
one such multidisciplinary TOO model. Although 
established virtual care centres for oral oncology 
currently operate in institutions in some countries,[19] 
disparities in health-care across countries have 
limited their widespread implementation.
Outreach Services to Underserved Areas
Access to high-speed internet is central for delivering 
teleoncology services. Rural medically underserved 
populations exist in both developing and developed 
countries and represent the main challenge to 
TOO accessibility. High-income countries – such 
as the U.S., Germany, Norway, Japan, Australia 
and others – have adopted teleoncology services 
proposed to serve remote and rural populations.[1] 
While the primary focus of most reviews on the 
effectiveness of teleoncology has not been on 
rural populations,[15] there has been a multitude of 
initiatives in low- and middle-income countries that 
have gained success, such as in Brazil, India, Jordan, 
Russia and other countries.[1] Some telemedicine 
networks are provided by high-income countries 
to various countries of the developing world for 
clinical purposes in two areas; disaster relief and for 
second opinions.[20] Interestingly, the lack of high-
speed internet services is not the only factor that 
hinders teleoncology services in remote areas, but 
rather, the demand for telemedicine in developing 
countries is not being met largely due to human 
factors such as perceiving a lack of value in these 
services and the lack of appropriately qualified 
telemedicine experts in these areas.[1,20] Likewise, 
such factors will indeed affect TOO adoption by 
developing countries, emphasising a crucial need 
for seminars and continuing education programs 
that spread awareness of the benefits of TOO for 
Figure 1: A working model for TOO. This proposed model consists of a secure entralized database that contains 
deidentified diagnostic and health-related information from the patient’s primary site of oral cancer care. The primary 
site inputs health-related information from different individual databases. Oral medicine inputs the clinical images of 
the lesion and the relevant clinical history. Oral pathology inputs a virtually scanned histopathology slide (and slides 
with other diagnostic markers if applicable). Oral radiology inputs the radiographic images. Oral surgery inputs the 
tumour stage and proposed surgical plan. The oncology team inputs any genomic information and the proposed 
chemoradiation and/or immunotherapy plan. Maxillofacial prosthodontics inputs information of the proposed 
reconstruction plan. Experts from multidisciplinary specialties at remote or distant sites then access this secure 
entralized database that contains the holistic patient record. International experts from different disciplines of the 
multidisciplinary TOO team will be registered on a global database. This database will be used to locate experts with 
the relevant expertise to provide consultations. The TOO multidisciplinary team engages in consensus and provides 
expert consultation and treatment recommendations ensuring a precision medicine-centred approach. Note the 
dotted lines reflect the transfer of data
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oral cancer patients in these countries. Dental 
hygienists and general dentists are often the 
first health professionals to detect abnormalities 
in the oral cavity, and hence, their awareness 
of the significance of TOO is indispensable. 
In fact, one study highlighted the importance 
of smart mobile phones as a reliable platform 
that facilitated consultation in cases related to 
oral medicine for general dentists and dental 
hygienists.[21] In this study, the agreement between 
tele-oral medicine diagnosis and the definitive 
clinicopathologic diagnosis issued by experts 
was 71% for premalignant and malignant lesions 
through using WhatsApp as the telemedicine 
platform.[21]
Learning
Both developed and developing countries 
use telemedicine for either interactive or long-
distance learning.[20] Indeed, internet-based 
resources are available for dental and medical 
students and residents who are involved in oral 
cancer health care. Examples include online case 
sharing websites such as Case of the Month by 
pathologyoutlines.com, surgical pathology cases 
by webpathology.com, the Image Challenge 
section of the New England Journal of Medicine 
and Case of the Month Archives offered by the 
University of Washington Dental School. Video 
conferences are also being used by consultants 
and senior health-care professionals to monitor 
the medical training of junior medical professionals 
involved in care administration in rural areas in real 
time.[22] Distant learning and training supervision 
can also be applied to TOO. The Bulletin Board 
for Oral Pathology is a platform where oral and 
maxillofacial pathologists, oral medicine specialists 
and other health specialists share opinions and 
announcements about oral health practices, 
research and teaching.
Consultation
Oral and maxillofacial pathology and oral medicine 
are closely related specialties that are vital to 
oral cancer diagnosis and management; hence, 
clinicopathological correlation is important to 
reach a definitive diagnosis. This is particularly 
important when subjective macroscopic and 
microscopic criteria exist for the diagnosis of 
potentially malignant oral mucosal abnormalities or 
when complex cases of undifferentiated epithelial 
and mesenchymal malignancies occur. For 
example, a white well-demarcated flat lesion with 
no apparent cause can present microscopically 
as keratosis of unknown significance, epithelial 
dysplasia, carcinoma in situ or invasive squamous 
cell carcinoma, the most common malignancy of 
the oral cavity proper. Each of these microscopic 
diagnoses harbour a degree of intra-  and inter-
observer variability, and based on the diagnosis 
rendered, they can be managed differently[23] 
from minimally invasive treatments to extensive 
surgery and/or chemoradiation. Such lesions are 
often peer-reviewed or brought to consensus 
conferences for discussion which might need the 
input of experts at distant sites. This is a rather 
common scenario that outlines the significance 
of tele-oral medicine and pathology; two crucial 
components of TOO. Fortunately, histopathologic 
slides can be scanned (through Aperio ScanScope 
for instance) and shared on a common interactive 
platform. To date, there is a lack of regional, 
national and international platforms shared by 
health-care institutes that enable histopathology 
consults remotely.
Limitations and Medicolegal Considerations
Potential barriers for TOO providers are likely 
to be related to differences in practice licenses’ 
requirements between states and countries to 
render diagnoses and the absence of a sustainable 
reimbursement model for practitioners.[24] The 
initial financial cost of establishing TOO networks 
and platforms in developing countries is likely a 
significant limiting factor.[8] Experts in telehealth 
should be consulted when building TOO networks 
for the projected model to be sustainable and 
cost effective in the long run and to promote 
widespread implementation.[20,25,26]
The availability of specialists with relevant 
expertise is a notable limiting factor, especially 
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in underserved or rural areas. Therefore, in our 
proposed model [Figure  1], to overcome this 
human resource barrier, we envisage a registered 
database of global experts of all disciplines of 
the multidisciplinary TOO team that can provide 
consultation for cases from underserved or rural 
areas.
A potential limitation of image sharing in TOO is 
the production of low quality or out-of-focus photos 
to convey the clinical picture to distant health 
practitioners.[21] In addition, the lesion’s consistency, 
texture, margins and involvement of surrounding 
structures may be difficult to ascertain without 
clinical palpation. Further, another shortcoming 
of TOO is that lymph node examination cannot 
be performed, thus limiting a thorough head-
and-neck examination. When clinical or histologic 
static images are used as compared to real-time 
conferencing, a limited view angle or visual field 
of view can obscure key diagnostic features.[21,27] In 
addition, using imaging modalities for evaluating 
pigmented lesions can result in misdiagnosis of 
some cases (e.g., amelanotic melanoma).[27]
There has been a surge in the number of informal 
consultations on social media platforms such 
as Twitter; therefore, caution should be taken 
when accessing information from unverified 
sources.[28] In addition, the distinction between 
obtaining an informal virtual curbside consult 
and a formal consult should be established at 
the outset, as in the latter case, more serious 
medicolegal considerations exist. It is imperative 
that the patient’s consent is obtained before 
sharing clinical information and importantly, the 
patient sensitive information or identifiers should 
not be shared when informal TOO consults are 
obtained. Moreover, diagnostic opinions that are 
shared publicly, especially if incorrect, may result 
in diagnostic delays and negative psychosocial 
consequences for patients. A  cautious approach 
must be taken when interpreting opinions on 
diagnoses provided by respondents as the level 
of training and expertise can vary significantly 
between respondents and some may not be 
experts in the field.
The sharing of patient information across 
geographical locations is limited by institutional 
and sometimes jurisdictional policies. These 
policies are there to safeguard patient sensitive 
information. Hence, considerations of cybersecurity 
to prevent data breaches of the patient information 
must be taken into account when implementing 
TOO systems. Furthermore, stakeholders should 
maintain the privacy of patients’ information when 
operating through TOO systems in a manner 
similar to in-person appointments by applying strict 
Health Insurance Portability and Accountability 
Act (HIPAA) standards. Adopting these practices 
should give patients a sense of trust in TOO systems 
that their health records are safely accessible and 
confidential.[8,29]
Conclusions and Future Directions
TOO is expected to advance oral cancer care in 
the near future. Adopting TOO systems require 
the acceptance of all stakeholders involved while 
maintaining the same standards of health-care 
policies and regulations that govern personalised 
and confidential oral cancer management. This 
might necessitate centralising data and diagnostic 
material pooled from all arms of the multidisciplinary 
TOO team, into a digitalised seamless interactive 
platform [Figure  1]. Barriers such as initial cost, 
licensure hurdles and establishing universally 
accepted HIPAA compliant systems prevent 
the integration of TOO in routine oral cancer 
care. Nevertheless, with an anticipated increase 
in demand for TOO and with the progressive 
advancements in internet-based technologies, new 
policies and regulations issued by institutional and/
or governmental bodies through the guidance of 
International Health Organizations are needed to 
initiate the widespread access of multisite HIPAA 
compliant TOO systems. This will ensure access 
to patient electronic health information to all 
members of the multidisciplinary TOO team across 
different national and international sites.
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